Jeito Capital Co-leads EUR 65 Million (USD 71 M) Financing in Corteria Pharmaceuticals, a French Biopharmaceutical Company Developing Novel Treatments for Cardiovascular Diseases

Paris, France, Sept. 7 (Korea Bizwire) – Jeito Capital (“Jeito”), a global leading investment firm dedicated to healthcare and biopharma, announced today that it is co-leading a EUR 65m (USD 711M) Series A financing round in Corteria Pharmaceuticals (“Corteria” or the “Company”), a biopharmaceutical company specialized in the development of transformative therapies for unaddressed heart failure subpopulations. [...]